CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan

Background Oral squamous cell carcinoma (OSCC) is the fourth leading cause of male cancer death in Taiwan. Exposure to environmental carcinogens is the primary risk factor for developing OSCC. CD44, a well-known tumor marker, plays a crucial role in tumor cell differentiation, invasion, and metastasis. This study investigated CD44 single-nucleotide polymorphisms (SNPs) with environmental risk factors to determine OSCC susceptibility and clinicopathological characteristics. Methodology/Principal Findings Real-time polymerase chain reaction (PCR) was used to analyze 6 SNPs of CD44 in 599 patients with oral cancer and 561 cancer-free controls. We determined that the CD44 rs187115 polymorphism carriers with the genotype AG, GG, or AG+GG were associated with oral cancer susceptibility. Among 731 smokers, CD44 polymorphisms carriers with the betel-nut chewing habit had a 10.30–37.63-fold greater risk of having oral cancer compared to CD44 wild-type (WT) carriers without the betel-nut chewing habit. Among 552 betel-nut chewers, CD44 polymorphisms carriers who smoked had a 4.23–16.11-fold greater risk of having oral cancer compared to those who carried the WT but did not smoke. Finally, we also observed that the stage III and IV oral cancer patients had higher frequencies of CD44 rs187115 polymorphisms with the variant genotype (AG+GG) compared with the wild-type (WT) carriers. Conclusion Our results suggest that gene–environment interactions between the CD44 polymorphisms and betel quid chewing and tobacco smoking increase the susceptibility to oral cancer development. Patients with CD44 rs187115 variant genotypes (AG+GG) were correlated with a higher risk of oral cancer development, and these patients may possess greater chemoresistance to advanced- to late-stage oral cancer than WT carriers do. The CD44 rs187115 polymorphism has potential predictive significance in oral carcinogenesis and also may be applied as factors to predict the clinical stage in OSCC patients.

[1]  Laura H. Tang,et al.  Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma , 2011, International journal of cancer.

[2]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[3]  C. Molony,et al.  Genetic analysis of genome-wide variation in human gene expression , 2004, Nature.

[4]  I. Nazarenko,et al.  CD44 and EpCAM: cancer-initiating cell markers. , 2008, Current molecular medicine.

[5]  T. Tan,et al.  Wogonin Induces Reactive Oxygen Species Production and Cell Apoptosis in Human Glioma Cancer Cells , 2012, International journal of molecular sciences.

[6]  K. Sakakura,et al.  Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. , 2009, Oral oncology.

[7]  L. Bourguignon,et al.  Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. , 2011, The American journal of pathology.

[8]  G. Baretton,et al.  Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. , 1999, Oral oncology.

[9]  Y. Ko,et al.  A case-control study of oral cancer in Changhua County, Taiwan. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[10]  B. Shastry.  SNPs: impact on gene function and phenotype. , 2009, Methods in molecular biology.

[11]  Dong M Shin,et al.  Recent advances in head and neck cancer. , 2008, The New England journal of medicine.

[12]  T. Shieh,et al.  Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[13]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[14]  S. Goodison,et al.  CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.

[15]  M. Kahn,et al.  Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence , 2011, Clinical Cancer Research.

[16]  A. Stepan,et al.  The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC). , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[17]  P. Herrlich,et al.  A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. , 1993, Cancer research.

[18]  M. Zöller,et al.  CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation , 2003, Journal of Molecular Histology.

[19]  A. Levine,et al.  Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. , 2010, Cancer research.

[20]  W. Yeh,et al.  Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. , 2012, Neuro-oncology.

[21]  F. Hoebers,et al.  CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer , 2010, Clinical Cancer Research.

[22]  S. Jalkanen,et al.  Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. , 2003, Cancer research.

[23]  M. Nagarkatti,et al.  Unique SNP in CD44 intron 1 and its role in breast cancer development. , 2010, Anticancer research.

[24]  A. Godwin,et al.  Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. , 2002, The American journal of pathology.

[25]  J. Nör,et al.  The biology of head and neck cancer stem cells. , 2012, Oral oncology.

[26]  Yi-Wei Chen,et al.  Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma–Derived CD44+ALDH1+ Cells , 2010, Molecular Cancer Therapeutics.

[27]  F. Esteban,et al.  Prognostic significance of p21WAF1/CIP1, p16INK4a and CD44s in tongue cancer. , 2007, Oncology reports.

[28]  M. Herlyn,et al.  Stem-like cells and therapy resistance in squamous cell carcinomas. , 2012, Advances in pharmacology.

[29]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[30]  I. Mackenzie,et al.  Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma. , 2006, Oral diseases.

[31]  Yu-Hsin Lin,et al.  Phloroglucinol derivative MCPP induces cell apoptosis in human colon cancer , 2011, Journal of cellular biochemistry.

[32]  K. Alanen,et al.  Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. , 2011, Oral oncology.

[33]  I. Weissman,et al.  Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: Correlation with tumor aggressiveness , 2012, Head & neck.

[34]  Y. Ko,et al.  Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[35]  James S. Brown,et al.  Survival following primary surgery for oral cancer. , 2009, Oral oncology.

[36]  M. Kuo,et al.  Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[37]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[38]  G. Dunn,et al.  ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. , 2012, Cancer research.

[39]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[40]  CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations , 2012, Breast Cancer Research.

[41]  Y. Ko,et al.  Prevalence and characteristics of areca nut chewers among junior high school students in Changhua county, Taiwan. , 1993, Community dentistry and oral epidemiology.

[42]  M. Hung,et al.  Hyaluronan Promotes CD44v3-Vav2 Interaction with Grb2-p185HER2 and Induces Rac1 and Ras Signaling during Ovarian Tumor Cell Migration and Growth* , 2001, The Journal of Biological Chemistry.

[43]  P. Herrlich,et al.  Regulation of alternative pre‐mRNA splicing by the ERK MAP‐kinase pathway , 2001, The EMBO journal.

[44]  M. Goodell,et al.  A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[46]  B. Weissman,et al.  The BRG-1 Subunit of the SWI/SNF Complex Regulates CD44 Expression* , 2001, The Journal of Biological Chemistry.

[47]  Chava Kimchi-Sarfaty,et al.  Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. , 2007, Cancer research.

[48]  P. Johnston,et al.  The emerging role of CD44 in regulating skeletal micrometastasis. , 2006, Cancer letters.

[49]  Zhi-Hua Zhu,et al.  Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma , 2010, Journal of Cancer Research and Clinical Oncology.

[50]  W. Lin,et al.  The association of smoking, alcoholic consumption, betel quid chewing and oral cavity cancer: a cohort study , 2008, European Archives of Oto-Rhino-Laryngology.

[51]  Matthew W. Strobeck,et al.  Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. , 2002 .